Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
12/2003
12/11/2003CA2488219A1 Agents for imaging and diagnostic methods using them
12/11/2003CA2487720A1 Therapeutic agent-containing polymeric nanoarticles
12/10/2003EP1368310A2 Improved methods of ortho alkylation
12/10/2003EP1368309A2 Thiol-modified hyaluronan
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368307A2 A method of making a calcium salt of 2-hydroxy-4-(mercaptomethyl)butanoic acid
12/10/2003EP1368300A1 Substituted amino dicarboxylic acid derivatives
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003CN1461296A Bis (4-mercaptophenyl) sulfide derivatives, process for preparation thereof and electronic components
12/10/2003CN1461292A 1,4-diaryl-2,3-difluoro-2-butene insecticidal and acaricidal agents
12/10/2003CN1130325C Aliphatic alkane aldehyde having better storage stability and method raising storage stability
12/09/2003US6660885 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
12/09/2003US6660880 Esterification of the corresponding acid with alcohol in presence of acid catalysts
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660246 Ligands and metal complexes thereof
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/04/2003WO2003099777A1 Process for the preparation of thioalkylamine derivatives
12/04/2003WO2003099774A1 Preparations of a sulfinyl acetamide
12/04/2003WO2003099773A1 Ccr9 inhibitors and methods of use thereof
12/04/2003WO2003099763A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
12/04/2003WO2003099409A1 Method for producing specific crystalline modifications of polymorphous substances
12/04/2003WO2003059875A3 DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2002049641A3 Anti-endoparasitic amidoacetonitrils
12/04/2003US20030225296 Functionalized metal complexes
12/04/2003US20030225287 Synthesis of chiral 2-alkyl amino acids
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/04/2003US20030225091 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes
12/04/2003US20030225075 Novel pyrimidone derivatives
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224250 Asymmetric acrylate or vinyl ether compound containing sulfide groups, aromatic moieties, and optionally bromine is mixed with a matrix polymer precursor (expecially polyurethane) and reacted; holography recording medium
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/03/2003EP1366440A2 Method of operating a computer system to perform a discrete substructural analysis
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366020A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity
12/03/2003EP1161417B1 Methods and compositions for treating leukemia
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/02/2003US6657093 Preparation of substituted aromatic compounds
12/02/2003US6657086 For reducing weight in mammals; preventing and treating obesity
12/02/2003US6656968 (Z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656961 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
12/02/2003US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity
12/02/2003US6656710 Racemization of preferential amino acids; obtain chemical intermediate, incubate with preferential enzyme, recover amino acid
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
11/2003
11/27/2003WO2003097792A2 Polypeptide immobilization
11/27/2003WO2003097622A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
11/27/2003WO2003097582A2 Synthesis of benzonitriles and benzimidates
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003096987A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003WO2003096978A2 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (pet) imaging for the brain serotonin transporters
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003US20030220524 A Sulfone disulphides derivatives, a reaction product from chemical intermediates by carboxylation, esterification and sulfonation; use as fungicides, antiproliferative agents, antitumor agents
11/27/2003US20030220505 Process and novel intermediates for preparing isoxazolin-3-ylacyl benzenes
11/27/2003US20030220504 Forming a phenyl-thiazoles chemical intermediates for making antioxidants, ferrielectric liquid crystal dopant, picornaviral viricides, antiinflammatory agents, anti-asthma agents, and fibringoen antagonists
11/27/2003US20030220469 Novel compound used as an amino-protecting group, process for preparing the same, and synthetic method of a peptide using the same
11/27/2003US20030220468 Modified forms of pharmacologically active agents and uses therefor
11/27/2003US20030220429 A heat resist polyvinyl chloride comprising a mercaptophenyl ester derivatives; nondeforming, discoloration inhibition
11/27/2003US20030220371 Administering to a mammal an aromatic or heteroaromatic ring substituted triazole derivative to treat the conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, and obesity
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2485586A1 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003CA2456698A1 Polypeptide immobilization
11/26/2003EP1364943A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors
11/26/2003EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003CN1128777C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
11/25/2003US6653309 Binding ligands
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003CA2134679C Soluble analogs of probucol
11/25/2003CA2064349C Stereoisomeric enrichment of 2-amino-3-hydroxy-3-phenylpropionic acids
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003095526A1 Novel sulfurized phenolic resin, process for producing the same, phenol derivative having thioether structure or disulfide structure, process for producing the same, and epoxy resin composition and adhesive
11/20/2003WO2003095420A1 Hydroxy tetrahydro-naphthalenylurea derivatives
11/20/2003WO2003066572B1 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/20/2003WO2002089229A3 Bistable molecular mechanical devices with a middle rotating segment activated by an electric field for electronic switching, gating, and memory applications
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216580 Herbicide active materials
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216493 Odorless heat stabilizer
11/20/2003US20030216468 Thiol-based NAALADase inhibitors
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216260 Preparation by intramolecular cyclization
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 272